ID
REGN icon

Integral Derivatives’s Regeneron Pharmaceuticals REGN Stock Holding History

Integral Derivatives’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.89M Sell
5,500
-400
-7% -$139K 0.05% 123
2017
Q4 		$2.22M Sell
5,900
-200
-3% -$81K 0.04% 265
2017
Q3 		$2.73M Sell
6,100
-3,300
-35% -$1.57M 0.05% 243
2017
Q2 		$4.62M Buy
9,400
+4,000
+74% +$1.75M 0.1% 123
2017
Q1 		$2.09M Sell
5,400
-1,100
-17% -$408K 0.04% 300
2016
Q4 		$2.39M Sell
6,500
-2,900
-31% -$1.1M 0.04% 277
2016
Q3 		$3.78M Buy
9,400
+3,200
+52% +$1.28M 0.08% 149
2016
Q2 		$2.17M Buy
6,200
+1,300
+27% +$501K 0.05% 224
2016
Q1 		$1.77M Buy
4,900
+1,000
+26% +$412K 0.06% 247
2015
Q4 		$2.12M Buy
3,900
+2,200
+129% +$1.19M 0.05% 261
2015
Q3 		$791K Buy
1,700
+1,100
+183% +$591K 0.02% 566
2015
Q2 		$306K Sell
600
-1,700
-74% -$830K 0.01% 863
2015
Q1 		$1.04M Sell
2,300
-12,200
-84% -$5.17M 0.02% 503
2014
Q4 		$5.95M Buy
14,500
+8,000
+123% +$3.15M 0.1% 162
2014
Q3 		$2.34M Sell
6,500
-1,000
-13% -$335K 0.04% 405
2014
Q2 		$2.12M Sell
7,500
-2,500
-25% -$741K 0.04% 401
2014
Q1 		$3M Sell
10,000
-7,200
-42% -$2.22M 0.06% 297
2013
Q4 		$4.73M Buy
+17,200
New +$4.95M 0.07% 252

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Integral Derivatives's REGN Position: Q1 2018 in Review

Integral Derivatives opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2018: 831 shares worth $286K. The stake represents 0.01% of the portfolio and ranks #520 among its holdings. This is a return to the name: Integral Derivatives previously reported a position in REGN as recently as Q2 2017.

Integral Derivatives first reported a position in REGN in Q3 2015 and has held it in 8 quarters since. The position peaked at $1.23M in Q1 2016. 619 funds tracked by Wall St. Rank hold REGN as of Q1 2018.

  • Integral Derivatives held 831 shares of Regeneron Pharmaceuticals worth $286K as of Q1 2018.
  • Regeneron Pharmaceuticals was a new Integral Derivatives position in Q1 2018.
  • Regeneron Pharmaceuticals made up 0.01% of Integral Derivatives's portfolio in Q1 2018, its #520 holding.
  • Integral Derivatives first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 8 quarters since.
  • Integral Derivatives's Regeneron Pharmaceuticals position peaked at $1.23M in Q1 2016.
  • 619 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.